Elicio Therapeutics Inc. (ELTX) — Cash Flow Reinvestment Rate
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Reinvestment Rate of 0.09x as of June 2022, reinvesting $559.00K (capex $559.00K ) from operating cash flow of $6.14 Million. Check ELTX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Elicio Therapeutics Inc. Cash Flow Reinvestment Rate (2012–2013)
Historical reinvestment intensity for Elicio Therapeutics Inc. across 2 annual periods. Explore debt repayment capacity of Elicio Therapeutics Inc. to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Elicio Therapeutics Inc. (2012–2013)
Year-by-year capital reinvestment analysis for Elicio Therapeutics Inc.. For live market cap and broader valuation context, see Elicio Therapeutics Inc. (ELTX) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2013 | 0.01x | $17.57K | $1.89 Million | $17.57K | ▼ -79.3% |
| 2012 | 0.04x | $47.73K | $1.07 Million | $47.73K | — |